Device to identify viable myocardium gets National Institutes of Health (NIH) funding
This article was originally published in Clinica
Executive Summary
Energy Life Systems has received a US NIH grant to develop a fibreoptic catheter and method for monitoring the viability of heart tissue. The ability to distinguish between viable and infarcted myocardium "would be very useful in guiding treatment strategy and predicting outcome in many clinical situations, says Dr Charles Morcos of the University of California.
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.